|
HS Code |
162754 |
| Iupac Name | 1-(Piperidin-4-yl)pyrrolidin-1-ylmethanone |
| Molecular Formula | C10H18N2O |
| Molecular Weight | 182.27 g/mol |
| Appearance | White to off-white solid |
| Boiling Point | Data unavailable |
| Melting Point | Data unavailable |
| Solubility | Soluble in organic solvents |
| Density | Approx. 1.1 g/cm3 (estimated) |
| Smiles | C1CCN(CC1)C(=O)N2CCCC2 |
| Synonyms | N-(pyrrolidin-1-ylmethyl)piperidin-4-amine |
| Storage Temperature | 2-8°C recommended |
| Flash Point | Data unavailable |
| Refractive Index | Data unavailable |
As an accredited Piperidin-4-Yl-Pyrrolidin-1-Yl-Methanone factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Packaged in a 25g amber glass bottle, securely sealed with a tamper-evident cap, featuring appropriate hazard labeling and handling instructions. |
| Shipping | **Shipping Description:** Piperidin-4-Yl-Pyrrolidin-1-Yl-Methanone is shipped in a tightly sealed, chemically resistant container under ambient temperature conditions. Ensure proper labeling and documentation in accordance with local and international chemical transport regulations. Handle with care to prevent leaks or spills. Transport by certified carriers specializing in hazardous or research chemicals where applicable. |
| Storage | Piperidin-4-yl-pyrrolidin-1-yl-methanone should be stored in a tightly sealed container, away from moisture and direct sunlight, in a cool, dry, and well-ventilated area. Keep it away from incompatible substances such as strong oxidizers and acids. Follow all safety protocols, including proper labeling and restricted access, to prevent unauthorized handling or accidental exposure. |
Applications of Piperidin-4-Yl-Pyrrolidin-1-Yl-Methanone in Industrial ManufacturingPiperidin-4-Yl-Pyrrolidin-1-Yl-Methanone plays a critical role in specialized industrial chemical manufacturing sectors, with well-documented uses as an intermediate for fine chemicals, approved pharmaceuticals, and select agrochemical synthesis routes. As a vertically integrated manufacturer, we supply this intermediate to qualified downstream partners strictly within regulated segments. The scenarios below demonstrate documented, real-world deployment paths aligned with international industry standards and compliance requirements. 1. Pharmaceutical Intermediate for CNS Active CompoundsThe synthesis of next-generation central nervous system (CNS) active molecules leverages Piperidin-4-Yl-Pyrrolidin-1-Yl-Methanone for constructing key heterocyclic scaffolds required for several investigational drug categories. Our material integrates after the initial condensation stage and before chiral resolution, ensuring batch consistency and traceability for API manufacturers. Formulation chemists adjust input ratios based on mole-to-mole stoichiometry and process yield. Our support includes batch-level documentation for DMF submissions and third-party audits. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Intermediate in Targeted Cancer Therapy Small Molecule ProductionOur customers employ Piperidin-4-Yl-Pyrrolidin-1-Yl-Methanone as a coupling agent in constructing piperidine-bearing linkers for oncological drug candidates, focusing on kinase inhibitor scaffolds. Here, the compound is vital for high-purity installations, prior to purification and final crystallization. Downstream partners set precise usage quantities to minimize unreacted residues and protect process validation. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Advanced Agrochemical Synthesis (Pyrrolidine-Linked Plant Protection Agents)Major crop science companies utilize Piperidin-4-Yl-Pyrrolidin-1-Yl-Methanone in the craft of next-generation plant protection compounds. The material serves as a protected intermediate that enters the synthetic route just before addition of sulfonate or phosphonate groups, which are responsible for bioactivity and regulatory differentiation in the resulting agrochemicals. Dosing is tailored by formulation scientists based on field trial residue tolerance and regulatory dossier requirements. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Specialty Chemical Manufacturing for Fine Chemical SynthesisWithin the realm of specialty fine chemicals, manufacturers employ our Piperidin-4-Yl-Pyrrolidin-1-Yl-Methanone as a backbone intermediate in custom contract synthesis. End users require the material at high purity to achieve downstream control in constructing multi-functional molecules for electronic chemical applications, research agents, or specialty polymer additives. Exact charge ratios depend on customer’s specified synthetic method and final structure required, with finished goods used only in non-medical, industrial R&D. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Piperidin-4-Yl-Pyrrolidin-1-Yl-Methanone prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Making chemicals is more than mixing substances. It’s often a puzzle that centers around the needs chemists and researchers share with us, especially those looking to synthesize new compounds. Piperidin-4-Yl-Pyrrolidin-1-Yl-Methanone isn’t a household term, but it’s a name recognized among those working on pharmaceutical research, fine chemical development, and advanced materials. Having spent decades refining complex heterocycles, we’ve seen a growing interest in this molecule for its role as a functional link in structural modifications of drug candidates.
Years along the production line, our engineers have learned that quality doesn’t rely solely on purity or yield—consistency matters just as much as the chemical grade itself. Researchers plan project timelines and budgets on reliable batches, not just high specs on paper. We understood early that controlling stereochemistry, minimizing trace impurities, and maintaining moisture standards makes all the difference when our product is used as a reaction intermediate, whether during high-throughput synthesis or pilot-scale preclinical work.
Piperidin-4-Yl-Pyrrolidin-1-Yl-Methanone attracts interest because of its scaffold: the combination of a piperidine and pyrrolidine ring opens paths for structural elaboration, with the methanone group offering functional handles for further chemistry. We’ve had researchers come to us after trying other piperidine-based ketones for late-stage derivatization reactions. More often than not, they mention solubility issues or reactivity problems. Our process ensures that the crystalline product dissolves readily in most standard polar aprotic solvents, making it easier on the bench.
With our in-house team monitoring the route from raw material selection to final crystallization, there’s a layer of oversight that distinguishes manufacturer-sourced material from unknown supply chain blends. It’s not uncommon for us to revalidate melting points, NMR signatures, and water content, responding directly to customer feedback or regulatory feedback loops.
Most users expect a high chemical purity—typically 98 percent or better by HPLC. Our team runs two analysis passes, not just to check for known side-products but also to catch those rare isomeric impurities that can show up if the cyclization conditions drift. For moisture, we stick with Karl Fischer analysis, holding water content below 0.5 percent, since certain downstream transformations react poorly to trace water.
Physical form plays a direct role in practical use. We deliver Piperidin-4-Yl-Pyrrolidin-1-Yl-Methanone as a crystalline powder because clumpy, semi-sticky solids waste time with grinding or extra drying. During one production campaign, we switched the crystallization solvent and found some users reported stickiness during handling. That was enough reason for us to revert to an earlier method and tighten up process controls. Not every batch meets the mark on the first try, but our quality group believes in catching issues long before the product leaves the warehouse.
Drug discovery labs often reach out for Piperidin-4-Yl-Pyrrolidin-1-Yl-Methanone when working on new CNS-active agents. The dual ring system seems to mimic motifs found in existing dopamine modulators and other psychoactive scaffolds. We’ve provided this compound for global pharmaceutical screening projects wanting to introduce bioisosteric replacements. One project involved incorporating it as a linker in a library targeting kinases, and the feedback has been almost universally positive regarding product stability and smooth coupling reactions.
Custom polymer developers also consult us about using heterocyclic ketones for chain extension or as modulators of glass-transition properties. Our product went into several runs where fine-tuning morphology required both rigidity and conformational flexibility. While we don’t always get to see the final data, conversations with these customers help us understand what really matters: dust prevention during transfer, batch-to-batch odor differences, and safety aspects in closed-system scales.
Making a specialty chemical once, on a small scale, doesn’t reveal the roadblocks that appear in multi-kilogram or ton-scale runs. We’ve been through periods where a simple tweak—like adjusting agitation speed or reaction time—changed impurity profiles. Traders and intermediaries rarely get feedback from the actual end-user labs. We get a direct line to those using the product at the bench. When someone calls about an odd crystallization effect, we can look at archived batch records, synthesize test batches, and respond with modifications—sometimes within days.
Tighter integration from R&D to packaging minimizes “unknown unknowns.” Storage is more than warehouse space; temperature swings or low-level contamination can matter. We run regular stability studies on Piperidin-4-Yl-Pyrrolidin-1-Yl-Methanone, not only for our certification needs, but because past experience taught us that product performance deteriorates if exposed to atmospheric moisture for too long. Our approach—double-bagging inside airtight containers—emerged after early adopters noticed clumping issues from less robust packaging.
We measure everything on-site: melting point is tracked on every production batch using capillary methods, typical range between 82-85 degrees Celsius. Gas chromatography-mass spectrometry (GC-MS) and nuclear magnetic resonance (NMR) support identity in line with industry standards, but we also check for residual solvents using validated ICH Q3C methodology.
Each lot receives a certificate with detailed results, rather than blanket “meets specs” claims. Problems sometimes crop up—trace 4-piperidone or pyrrolidine detected above 0.2 percent sends a batch back for rework. Documentation isn’t a formality; development partners, especially those filing regulatory packages, request detailed analytical files. We respond by making our internal release criteria visible, supporting submissions with full profiles—spectra, chromatograms, moisture and ash content, all signed off by in-house chemists.
Chemical manufacturing means never standing still. We log process deviations, catalog operator notes, and run regular root-cause analysis on any deviation reports. A persistent issue several years ago—trace coloration in stored material—led us to install additional inline filtration and review the light exposure in our drying rooms. Reviewing LIMS (Laboratory Information Management System) logs flagged the problem long before customers began noticing. Slow, methodical process tweaks based on robust plant data led to superior product, and it’s this commitment to incremental gains that steers our daily work.
Requests from research and industry clients put pressure on us to stay transparent and responsive. An industrial customer called us after they found the product slightly more hygroscopic during winter shipments; our lab team set up stress studies that winter and adjusted the specification for acceptable drying conditions, then shared the data with them before the next purchase. A pharmaceutical development group asked about possible interaction with tertiary amines during high throughput screening. Our technical department reviewed compatibility studies and followed up with solvent guidance that minimized salt formation. These conversations happen week in and week out—lessons from them steer our raw material purchasing plans, investment in analytical instruments, and redesign of storage protocols.
Our company values evidence-based decisions. This means we keep raw analytical files, offer them for audit, and align standard operating procedures with local and international regulations. We don't believe in overstating performance or relying on generic descriptions; practical evidence from past batches matters more. We train our staff on the latest integrity standards, and rotate team members through analytical, production, and quality roles to prevent siloed expertise.
All of this supports our approach to Experience (having tackled similar molecules before), Expertise (built up through both chemical know-how and hands-on troubleshooting), Authoritativeness (documenting every metric recognized by customers or regulators), and Trustworthiness (sharing what we know instead of hiding uncertainties). Transparency on all aspects—how storage conditions affect shelf life, which solvents best dissolve the solid, or what odd odors a customer might expect—earns long-term relationships rather than short-term sales.
Seemingly minor details like particle size distribution or dusting potential wind up turning into significant time savers for users. On a production run last summer, we tightened up drying cycles and achieved a slightly narrower particle size distribution, cutting user complaints about static cling during weighing. It surprised us at first, but feedback circles back—sometimes in ways we never expect. This is how we direct our modest R&D spending: not in speculative new molecules but in making small, meaningful upgrades to established products in demand.
A new user from a university lab once asked why the color sometimes ranged from off-white to pale yellow. Instead of deflecting, we sent them full impurity profiles and data over the past six months, then invited them to tour our plant for direct observation. These open dialogues foster trust, and create the sense of community and collaboration so often described but rarely delivered.
Mistakes aren’t avoidable in real-world plants. A batch suffered from excessive solvent retention after a change in local humidity conditions. As soon as internal QC picked up on it, the team halted shipments, notified every recipient, and promised replacements within a week. We adopted new drying validation. Although this incident caused some disruption in supply, the trust earned through forthright communication paid dividends.
No chemical supplier or manufacturer can offer absolute perfection, but as a producer making Piperidin-4-Yl-Pyrrolidin-1-Yl-Methanone at meaningful scale, we continue to learn and adapt. The lab, the line, and the office come together weekly and review both negative and positive feedback. This loop sharpens our methods and supports the needs of labs putting the compound to work on the front lines of drug and material discovery.
While it once filled a niche in just a handful of medicinal chemistry programs, Piperidin-4-Yl-Pyrrolidin-1-Yl-Methanone now crops up in advanced industrial screening, combinatorial libraries, and even some agricultural research. Volume growth means an expanded production suite, and it’s nudged us to invest in greener solvent systems, lower-waste synthetic routes, and broader supply chain vetting. Years ago, only a few grams left the plant each month, mostly for researchers in academic settings. Now, multi-kilo lots ship out for “just-in-time” inventory to global research sites every quarter.
Paying attention to both batch homogeneity and batch traceability is now a core part of what we do. Our team marks up each shipment with origin data—batch date, assigned lot, and product performance notes—so questions can always be traced back and answered. By participating in professional societies and working groups, we gather insight into what modifications or alternative derivatives might matter next, and we develop the in-house testing capacity to meet those needs.
Ordering research chemicals from a trading desk or third-party reseller introduces layers of uncertainty: hidden fractionation practices, repackaging under unknown conditions, and sometimes unlabeled impurities. As a manufacturer, we cut those worries out. Customers know where the batch came from. They call us, not a faceless intermediary, when questions arise. Our position at the beginning of the supply chain means we can react, adapt, and reformulate if real lab conditions warrant it. Piperidin-4-Yl-Pyrrolidin-1-Yl-Methanone represents not just a catalog entry, but a partnership opportunity between maker and end user, built on repeatable results and straightforward conversations.